|
Oct 3
|
Enara Bio secures $32.5m for ‘Dark Antigen’ cancer therapies
|
|
Oct 3
|
Pfizer Inc. (PFE): A Low-Cost Stock with High Growth Potential
|
|
Oct 3
|
Qnovia set to trial smoking cessation inhaler in the US
|
|
Oct 3
|
Is Pfizer a Buy Right Now or a Value Trap?
|
|
Oct 2
|
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
|
|
Oct 2
|
Zacks Investment Ideas feature highlights: Coca-Cola, Pfizer and Altria
|
|
Oct 2
|
3 Sensational Ultrahigh-Yield Dividend Stocks That Make for No-Brainer Buys in the 4th Quarter (and Beyond)
|
|
Oct 1
|
The Covid Era Tech Promises To Reinvent Cancer Treatment
|
|
Oct 1
|
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
|
|
Oct 1
|
3 Consistent Dividend Stocks for Passive Income: KO, PFE, MO
|
|
Oct 1
|
Zacks.com featured highlights include GIII Apparel Group, Sonoco Products, Hamilton Insurance Group, Pampa Energia S.A. and Pfizer
|
|
Oct 1
|
Pfizer Inc. (PFE): Is This A Good Stock to Buy for Long Term?
|
|
Oct 1
|
Pfizer Raises $3.2 Billion by Selling Part of Haleon Stake
|
|
Oct 1
|
Why Are Analysts Bullish On Pfizer Inc. (PFE) Right Now?
|
|
Oct 1
|
Pfizer to Receive 2.66 Billion Pounds From Haleon in Share Deal
|
|
Oct 1
|
Pfizer offloads $3.3 billion stake in Sensodyne-maker Haleon
|
|
Sep 30
|
Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
|
|
Sep 30
|
Bayer Reports Positive Safety Data on Parkinson's Disease Drug
|
|
Sep 30
|
Drug giant Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
|
|
Sep 30
|
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
|